共 25 条
- [1] Chemical Proteomic Characterization of a Covalent KRASG12C InhibitorACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (06): : 557 - 562论文数: 引用数: h-index:机构:Xiao, Junpeng论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAReutter, Christopher论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAFurness, Kelly W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USALeon, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAZia-Ebrahimi, Mohammad论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USACavitt, Rachel N.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAStrelow, John M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAVan Horn, Robert D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAPeng, Sheng-Bin论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USABarda, David A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAEngler, Thomas A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USAChalmers, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
- [2] Hindered Biaryl Bond Construction and Subsequent Diastereomeric Crystallization to Produce an Atropisomeric Covalent KRASG12C Inhibitor ARS-2102ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (01) : 206 - 216Yang, Xiaogen论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaLi, Zhiwen论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaXu, Wenwen论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaZhu, Guanming论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaFeng, Xiantong论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaZhang, Jun论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaZhao, Hongbin论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaChen, Yuyin论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaKong, Jianshe论文数: 0 引用数: 0 h-index: 0机构: WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaMai, Wanping论文数: 0 引用数: 0 h-index: 0机构: Wellspring Biosci Inc, San Diego, CA 92121 USA WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaLi, Lian-Sheng论文数: 0 引用数: 0 h-index: 0机构: Wellspring Biosci Inc, San Diego, CA 92121 USA Kumquat Biosci, 10770 Wateridge Circle,Ste 120, San Diego, CA 92121 USA WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaPippel, Daniel J.论文数: 0 引用数: 0 h-index: 0机构: Wellspring Biosci Inc, San Diego, CA 92121 USA Janssen Res & Dev LLC, San Diego, CA 92121 USA WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaRen, Pingda论文数: 0 引用数: 0 h-index: 0机构: Wellspring Biosci Inc, San Diego, CA 92121 USA WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R ChinaDeng, Xiaohu论文数: 0 引用数: 0 h-index: 0机构: Wellspring Biosci Inc, San Diego, CA 92121 USA WuXi AppTec Co, STA Pharmaceut Co Ltd, Shanghai 200131, Peoples R China
- [3] Discovery of AZD4625, a Covalent Allosteric Inhibitor of the MutantGTPase KRASG12CJOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (09) : 6940 - 6952Kettle, Jason G.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandBagal, Sharan K.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandBickerton, Sue论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandBodnarchuk, Michael S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandBoyd, Scott论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandBreed, Jason论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandCarbajo, Rodrigo J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandCassar, Doyle J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandChakraborty, Atanu论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandCosulich, Sabina论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandCumming, Iain论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandDavies, Michael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandDavies, Nichola L.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandEatherton, Andrew论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandEvans, Laura论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandFeron, Lyman论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandFillery, Shaun论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandGleave, Emma S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandGoldberg, Frederick W.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandHanson, Lyndsey论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Alderley Pk SK10 4TG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandHarlfinger, Stephanie论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandHoward, Martin论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandHowells, Rachel论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandJackson, Anne论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandKemmitt, Paul论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandLamont, Gillian论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandLamont, Scott论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandLewis, Hilary J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandLiu, Libin论文数: 0 引用数: 0 h-index: 0机构: Pharmaron Beijing Co Ltd, Beijing 100176, Peoples R China AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandNiedbala, Michael J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Waltham, MA 02451 USA AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandPhillips, Christopher论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandPolanski, Radek论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandRaubo, Piotr论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandRobb, Graeme论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandRobinson, David M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandRoss, Sarah论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandSanders, Matthew G.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandTonge, Michael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandWhiteley, Rebecca论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandWilkinson, Stephen论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandYang, Junsheng论文数: 0 引用数: 0 h-index: 0机构: Pharmaron Beijing Co Ltd, Beijing 100176, Peoples R China AstraZeneca, Oncol R&D, Cambridge CB4 0WG, EnglandZhang, Wenman论文数: 0 引用数: 0 h-index: 0机构: Pharmaron Beijing Co Ltd, Beijing 100176, Peoples R China AstraZeneca, Oncol R&D, Cambridge CB4 0WG, England
- [4] Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid TumorsJOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 52 - 65Lanman, Brian A.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAAllen, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAAllen, John G.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAAmegadzie, Albert K.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAAshton, Kate S.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USABooker, Shon K.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAChen, Jian Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAChen, Ning论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAFrohn, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAGoodman, Guy论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAKopecky, David J.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USALiu, Longbin论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USALopez, Patricia论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USALow, Jonathan D.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAMa, Vu论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAMinatti, Ana E.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USANguyen, Thomas T.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USANishimura, Nobuko论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAPickrell, Alexander J.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAReed, Anthony B.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAShin, Youngsook论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USASiegmund, Aaron C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USATamayo, Nuria A.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USATegley, Christopher M.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAWalton, Mary C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAWang, Hui-Ling论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAWurz, Ryan P.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAXue, May论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAYang, Kevin C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAAchanta, Pragathi论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Oncol Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USABartberger, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Mol Engn, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USACanon, Jude论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Oncol Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAHollis, L. Steven论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Discovery Attribute Sci, 360 Binney St, Cambridge, MA 02142 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAMcCarter, John D.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Discovery Technol, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAMohr, Christopher论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Mol Engn, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USARex, Karen论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Oncol Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USASaiki, Anne Y.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Oncol Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USASan Miguel, Tisha论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Discovery Technol, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAVolak, Laurie P.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Pharmacokinet & Drug Metab, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAWang, Kevin H.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Mol Engn, 360 Binney St, Cambridge, MA 02142 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAWhittington, Douglas A.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Mol Engn, 360 Binney St, Cambridge, MA 02142 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USAZech, Stephan G.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Discovery Attribute Sci, 360 Binney St, Cambridge, MA 02142 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USALipford, J. Russell论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Oncol Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USACee, Victor J.论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA Amgen Res, Dept Med Chem, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA
- [5] Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges aheadGENES & DISEASES, 2023, 10 (02) : 403 - 414Li, Hui-yu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China Univ Chinese Acad Sci, Beijing 100049, Peoples R China Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R ChinaQi, Wei-liang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China Univ Chinese Acad Sci, Beijing 100049, Peoples R China Nanchang Univ, Coll Pharm, Nanchang 330006, Jiangxi, Peoples R China Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R ChinaWang, Yu-xiang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R ChinaMeng, Ling-hua论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China Univ Chinese Acad Sci, Beijing 100049, Peoples R China Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, 501 Haike Rd, Shanghai 201203, Peoples R China Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
- [6] Development of covalent KRASG12C inhibitor APG-1842 for the treatment of solid tumorsCANCER RESEARCH, 2022, 82 (12)Gu, Shaoulai论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaLi, Qiang论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaLi, Chao论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaWang, Qixin论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaFang, Douglas D.论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaWang, Shaomeng论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Ann Arbor, MI 48109 USA Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaYang, Dajun论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R ChinaZhai, Yifan论文数: 0 引用数: 0 h-index: 0机构: Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China
- [7] The discovery and preclinical characterization of the potent covalent KRASG12C inhibitor UCT-001024CANCER RESEARCH, 2023, 83 (07)Rose, Tristin E.论文数: 0 引用数: 0 h-index: 0O'Boyle, Brendan M.论文数: 0 引用数: 0 h-index: 0Hilf, Justin A.论文数: 0 引用数: 0 h-index: 0Baker-Tripp, Emma L.论文数: 0 引用数: 0 h-index: 0Feng, Zhengao论文数: 0 引用数: 0 h-index: 0Yang, Kevin论文数: 0 引用数: 0 h-index: 0Bartberger, Michael D.论文数: 0 引用数: 0 h-index: 0Loson, Oliver C.论文数: 0 引用数: 0 h-index: 0O'Brien, Neil A.论文数: 0 引用数: 0 h-index: 0McDermott, Martina S.论文数: 0 引用数: 0 h-index: 0Kamranpour, Naeimeh论文数: 0 引用数: 0 h-index: 0Jia, Weiping论文数: 0 引用数: 0 h-index: 0Luo, Tong论文数: 0 引用数: 0 h-index: 0Ayala, Raul论文数: 0 引用数: 0 h-index: 0Glasby, John论文数: 0 引用数: 0 h-index: 0Stoltz, Brian M.论文数: 0 引用数: 0 h-index: 0Slamon, Dennis J.论文数: 0 引用数: 0 h-index: 0
- [8] Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRASG12CJOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 2422 - 2436Li, Amin论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaLi, Sujing论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaWang, Peng论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Biol Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaDang, Chaojie论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Proc Dev Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaFan, Xinrui论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaChen, Mengran论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaLiu, Dan论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Biol Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaLi, Fu论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaLiu, Huan论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Proc Dev Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaZhang, Wei论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Hits Discovery Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaWang, Yanping论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Pharmacol Dept, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R ChinaWang, Yinxiang论文数: 0 引用数: 0 h-index: 0机构: Jacobio Pharmaceut Grp Co Ltd, Beijing 100176, Peoples R China Jacobio Pharmaceut Grp Co Ltd, Med Chem Dept, Beijing 100176, Peoples R China
- [9] Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi ArylationORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (08) : 3313 - 3325Molinaro, Carmela论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USAWong, Nicholas论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USAWhite, Nicholas A.论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USASirois, Lauren E.论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USABigler, Raphael论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche & Cie AG, Dept Proc Chem & Catalysis, Synthet Mol Tech Dev, CH-4070 Basel, Switzerland Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USABindschaedler, Quentin P.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche & Cie AG, Dept Proc Chem & Catalysis, Synthet Mol Tech Dev, CH-4070 Basel, Switzerland Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USADo, Steven论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Discovery Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USAMalhotra, Sushant论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Discovery Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USAGosselin, Francis论文数: 0 引用数: 0 h-index: 0机构: Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA Genentech USA Inc, Dept Synthet Mol Proc Chem, South San Francisco, CA 94080 USA
- [10] Synthesis of Adagrasib (MRTX849), a Covalent KRASG12C Inhibitor Drug for the Treatment of CancerORGANIC LETTERS, 2023, : 944 - 949Chen, Cheng-yi论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USALu, Zhichao论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USAScattolin, Thomas论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USAChen, Chengsheng论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USAGan, Yonghong论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USAMcLaughlin, Mark论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA Mirati Therapeut, Chem Proc R&D, San Diego, CA 92121 USA